e-learning
resources
Paris 2018
Tuesday, 18.09.2018
COPD management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of Inhaled Long Acting Muscarinic Antagonist (LAMA) on Lung Functions in Adult Stable Bronchiectasis
M. Tungnantawiwat (Bangkok, Thailand), K. Kitinarong (Bangkok, Thailand)
Source:
International Congress 2018 – COPD management
Session:
COPD management
Session type:
Thematic Poster
Number:
4392
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Tungnantawiwat (Bangkok, Thailand), K. Kitinarong (Bangkok, Thailand). Effects of Inhaled Long Acting Muscarinic Antagonist (LAMA) on Lung Functions in Adult Stable Bronchiectasis. 4392
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
The Discovery and Development of AZD1402/PRS-060, an Inhaled, Potent and Selective Antagonist of the IL-4 Receptor Alpha
Source: International Congress 2018 – Basic pharmacology
Year: 2018
Comparative Efficacy of Long-Acting Muscarinic Antagonists in COPD: Real Life Study
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Acetylsalicylic Acid Prevents Intermittent Hypoxia-Induced Vascular Remodeling in a Murine Model of Sleep Apnea
Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia
Year: 2018
The Effect of Cordycepin and Simvastatin on Cigarettes Smoke Extract Induced Cytokine and Chemokine Production in Human Bronchial Epithelial Cells
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018
TLR7 Expression Reveals Novel Bronchodilating Mechanism of Imidazoquinoline Agonists
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Effects of Long Term Exogenous Apelin Application in Experimental Pulmonary Hypertension Model Created with Monocrotaline
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020
Aerobic Exercise Effects in Severe Asthma: Involvement of Lung Fibroblast (MRC-5) Cells and Kinins Signaling
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Metered Cryospray Modulates Bronchial Epithelial Gene Expression in Patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Interventional pulmonology: unity in diversity
Year: 2020
Aerobic Exercise Improves Asthma Phenotype in a Model of Severe Asthma: Involvement of Kinins
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Late Breaking Abstract - Chronic Hypoxia Promotes Pulmonary Venous Smooth Muscle Cells Proliferation by Upregulating Calcium Sensing Receptor
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018
Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Effects of Sustained and Intermittent Hypoxia on Human Lung Cancer Cells
Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing
Year: 2019
Bone Metabolism in OSAS Patients and the Effect of One Year Treatment with Non-Invasive Ventilation
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020
Creatine Supplementation Augments Chronic Allergic Airway Inflammation and Remodelling: from Mice to Human Evidence
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018
Single Cell RNA-seq Reveals Zinc Metabolism Defect of Alveolar Type II Cells with Aging in IPF
Source: ERS Lung Science Conference 2020
Year: 2020
RAGE Partially Mediates Cigarettes Smoke Extract induced Cytokine and Chemokine Production in Human Bronchial Epithelial Cells
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018
mTOR Pathway Activation Drives Lung-Cell Senescence and Emphysema in Chronic Obstructive Pulmonary Disease
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017
Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
A new Humanized Mouse Model for Idiopathic Pulmonary Fibrosis and Effects of Nintedanib Treatment
Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept